Antioxidant Defenses Confer Resistance to High Dose Melphalan in Multiple Myeloma Cells

Background: Multiple myeloma (MM) is the second most common hematological cancer after lymphoma. It is characterized by the accumulation of clonal malignant plasma cells within the bone marrow. The development of drug resistance remains a major problem for effective treatment of MM. Understand the m...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancers (Basel)
Päätekijät: Gourzones, Claire, Bellanger, Céline, Lamure, Sylvain, Gadacha, Ouissem Karmous, De Paco, Elvira Garcia, Vincent, Laure, Cartron, Guillaume, Klein, Bernard, Moreaux, Jérôme
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI 2019
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6521290/
https://ncbi.nlm.nih.gov/pubmed/30925767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11040439
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia